In the combination Antiretroviral Therapy era, HIV infection is today considered a manageable chronic disease rather than, as in the past, a fatal condition, therefore clinicians are challenged to address new topics such as frailty and age-related comorbidities.
This success of modern medicine caused a paradigm shift: as current treatments maintain long-term viral suppression in adherent patients, the main concern is currently the handling of major frailty conditions, instead of drug efficacy. Knowing and managing non-infectious HIV-associated diseases in ageing HIV patients is, nowadays, of pivotal importance.

The publication, dissemination, and furtherance of research and study on ageing of people living with HIV infection are the chief aims of Journal of HIV and Ageing (JHA). 

Specifically, JHA aims at addressing some relevant issues:

• A section will be devoted to non-infectious diseases specialists’ point of view. This to cope with ageing in a multidisciplinary management, and to avoid any self-referential approach.

• The “fourth 90” objective will be a topic of particular relevance for the Journal, as stated by the World Health Organization, to better understand the true health status of people living with HIV.

• Another relevant topic for JHA will be the vaccines among PLWH, in particular after the SARS-CoV-2 pandemic, aimed at the immune protection of this most vulnerable population.

Lastly, we will deal with a topic as relevant today as ever, not only in the field of the infectious diseases: the consensus on which are the essential investigations (and, conversely, which are the inappropriate ones) to diagnose and monitor co-morbidities, as well as their timing. Another main topic is their impact on the treatment choices. In fact, the clinical appropriateness is an important issue to which JHA will dedicate a vast space, following the example of the U.S.A. educational campaign known as “Choosing wisely”.

It is likely that the new deal will provide an incremental budget to healthcare institutions: these augmented provisions should be used without waste and inequality, strictly according to the best scientific evidence.

JHA will publish editorials, mini-reviews, full-length papers, short communications, and case reports related to all aspects of ageing and co-morbidity in HIV patients.

Manuscripts submitted to JHA must constitute original research reports. All authors must have agreed to the submission of a manuscript and are responsible for its content. The corresponding author is responsible for obtaining such agreement and for informing the co-authors of the manuscript’s status throughout the submission, review, and publication process. By submission of a manuscript to the journal, the authors guarantee that they have the authority to publish the work and that the manuscript, or one with substantially the same content, was not published previously, is not being considered or published elsewhere. 

All accepted articles will be available online www.jhamagazine.net/archive